BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23193072)

  • 21. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
    Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
    J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
    Matoba H; Sugano S; Yamaguchi N; Miyachi Y
    Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas.
    Lacroix L; Nocera M; Mian C; Caillou B; Virion A; Dupuy C; Filetti S; Bidart JM; Schlumberger M
    Thyroid; 2001 Nov; 11(11):1017-23. PubMed ID: 11762710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical study of glypican 3 in thyroid cancer.
    Yamanaka K; Ito Y; Okuyama N; Noda K; Matsumoto H; Yoshida H; Miyauchi A; Capurro M; Filmus J; Miyoshi E
    Oncology; 2007; 73(5-6):389-94. PubMed ID: 18511877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of homeobox B9 is associated with down-regulation of CD56 and extrathyroidal extension of tumor in papillary thyroid carcinoma.
    Kim JH; Kim YH; Han JH; Lee KB; Sheen SS; Lee J; Soh EY; Park TJ
    Hum Pathol; 2012 Aug; 43(8):1221-8. PubMed ID: 22225776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].
    Kornfehl J; Wilfing A; Hermann M
    Laryngorhinootologie; 1994 Apr; 73(4):183-8. PubMed ID: 8011021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.
    Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q
    Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas.
    Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF
    Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of MAGE A1-6 and the clinical characteristics of papillary thyroid carcinoma.
    Lee HS; Kim SW; Hong JC; Jung SB; Jeon CH; Park JW; Park SY; Lee KD
    Anticancer Res; 2013 Apr; 33(4):1731-5. PubMed ID: 23564824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin levels in patients with papillary thyroid cancer according to the presence of Hashimoto's thyroiditis.
    Park SH; Park CS; Kim YI; Nam-Goong IS; Kim YS; Lee JC; Choi JI; Park JW; Kim ES
    Asian Pac J Cancer Prev; 2015; 16(6):2447-51. PubMed ID: 25824779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis.
    Hammad MO; Elabbasy LM; Abd Elghaffar MA; Zaki MMA; Bazeed FB; Zahran MA
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e154-e161. PubMed ID: 30884127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
    Tan H; Ye K; Wang Z; Tang H
    Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of glutaminyl cyclases in thyroid carcinomas.
    Kehlen A; Haegele M; Menge K; Gans K; Immel UD; Hoang-Vu C; Klonisch T; Demuth HU
    Endocr Relat Cancer; 2013 Feb; 20(1):79-90. PubMed ID: 23183267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
    French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
    J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.